BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 2384920)

  • 1. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation.
    Cheng-Mayer C; Quiroga M; Tung JW; Dina D; Levy JA
    J Virol; 1990 Sep; 64(9):4390-8. PubMed ID: 2384920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.
    Shioda T; Levy JA; Cheng-Mayer C
    Nature; 1991 Jan; 349(6305):167-9. PubMed ID: 1986308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.
    Chesebro B; Nishio J; Perryman S; Cann A; O'Brien W; Chen IS; Wehrly K
    J Virol; 1991 Nov; 65(11):5782-9. PubMed ID: 1920616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1.
    Collman R; Balliet JW; Gregory SA; Friedman H; Kolson DL; Nathanson N; Srinivasan A
    J Virol; 1992 Dec; 66(12):7517-21. PubMed ID: 1433527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    Stevenson M; Haggerty S; Lamonica C; Mann AM; Meier C; Wasiak A
    J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue.
    Liu ZQ; Wood C; Levy JA; Cheng-Mayer C
    J Virol; 1990 Dec; 64(12):6148-53. PubMed ID: 2243391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
    Koito A; Harrowe G; Levy JA; Cheng-Mayer C
    J Virol; 1994 Apr; 68(4):2253-9. PubMed ID: 8139010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.
    Anderson S; Shugars DC; Swanstrom R; Garcia JV
    J Virol; 1993 Aug; 67(8):4923-31. PubMed ID: 8331733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.
    Chesebro B; Wehrly K; Nishio J; Perryman S
    J Virol; 1992 Nov; 66(11):6547-54. PubMed ID: 1404602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    Kowalski M; Bergeron L; Dorfman T; Haseltine W; Sodroski J
    J Virol; 1991 Jan; 65(1):281-91. PubMed ID: 1702159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.
    Kusumi K; Conway B; Cunningham S; Berson A; Evans C; Iversen AK; Colvin D; Gallo MV; Coutre S; Shpaer EG
    J Virol; 1992 Feb; 66(2):875-85. PubMed ID: 1731112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses.
    Lusso P; Lori F; Gallo RC
    J Virol; 1990 Dec; 64(12):6341-4. PubMed ID: 2243398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.
    Li Y; Hui H; Burgess CJ; Price RW; Sharp PM; Hahn BH; Shaw GM
    J Virol; 1992 Nov; 66(11):6587-600. PubMed ID: 1404605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120.
    McKeating JA; Bennett J; Zolla-Pazner S; Schutten M; Ashelford S; Brown AL; Balfe P
    J Virol; 1993 Sep; 67(9):5216-25. PubMed ID: 7688820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
    Cheng-Mayer C; Shioda T; Levy JA
    J Virol; 1991 Dec; 65(12):6931-41. PubMed ID: 1658383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures.
    O'Brien WA; Mao SH; Cao Y; Moore JP
    J Virol; 1994 Aug; 68(8):5264-9. PubMed ID: 8035523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
    Miller MD; Warmerdam MT; Gaston I; Greene WC; Feinberg MB
    J Exp Med; 1994 Jan; 179(1):101-13. PubMed ID: 8270859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism.
    Morikita T; Maeda Y; Fujii S; Matsushita S; Obaru K; Takatsuki K
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1291-9. PubMed ID: 9339846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.